Literature DB >> 9474720

Experimental posterolateral lumbar spinal fusion with a demineralized bone matrix gel.

M A Morone1, S D Boden.   

Abstract

STUDY
DESIGN: A controlled rabbit model of lumbar posterolateral intertransverse process arthrodesis was used to evaluate a bone graft substitute.
OBJECTIVE: To determine the efficacy of demineralized bone matrix gel as an autograft extender, using different ratios of demineralized bone matrix to autograft and to determine the efficacy of demineralized bone matrix as an autogenous bone graft enhancer by adding it to the usual quantity of autograft. SUMMARY OF BACKGROUND DATA: Autogenous bone is considered the most effective bone graft material for posterolateral lumbar arthrodesis, yet nonunions occur in up to 30% of patients. In addition, donor site complications may occur in 25-30% of patients. This has prompted the search for and investigation of bone graft extenders, enhancers, and substitutes. Commercially available demineralized bone matrix gel is one possible graft extender and enhancer, which, unlike mineralized allografts, has osteoinductive properties. Although the gel is in common use, the efficacy of demineralized bone matrix when used for posterolateral spine arthrodesis has not been examined in prospective clinical studies. Furthermore, no known animal studies have tested demineralized bone matrix gel in a posterolateral arthrodesis model.
METHODS: Forty-seven New Zealand white rabbits underwent bilateral posterolateral spine arthrodesis at L5-L6 using autogenous iliac crest bone graft alone or in combination with demineralized bone matrix. Four groups were formed on the basis of the ratio of autograft to demineralized bone matrix: autograft alone (3 mL), 100:0 group; autograft (3 mL) and demineralized bone matrix (1.5 mL), 100:50 group; autograft (1.5 mL) and demineralized bone matrix (1.5 mL), 50:50 group; and autograft (0.75 mL) and demineralized bone matrix (2.25 mL), 25:75 group. Rabbits were killed 6 weeks after surgery. Inspection, manual palpation, radiographic film, and histologic evaluation were used to assess fusion.
RESULTS: All groups had similar fusion rates (66-73%) based on manual palpation. Rabbits implanted with demineralized bone matrix had more mature fusion masses, evidenced by the greater trabecular bone formation seen on radiographic film and histologic study.
CONCLUSIONS: Demineralized bone matrix was effective as a graft extender when used in up to a 3:1 ratio with autograft in a rabbit posterolateral spine fusion model. When less than the standard volume of autograft was used, the addition of demineralized bone matrix gel lead to fusion success rates comparable to those of the standard amount of autograft alone. However, demineralized bone matrix did not increase the frequency of successful fusion when added to the standard amount of autograft.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9474720     DOI: 10.1097/00007632-199801150-00003

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  24 in total

1.  Repair of massively defected hemi-joints using demineralized osteoarticular allografts with protected cartilage.

Authors:  Siming Li; Xiaohong Yang; Shenghui Tang; Xunmeng Zhang; Zhencheng Feng; Shuliang Cui
Journal:  J Mater Sci Mater Med       Date:  2015-08-30       Impact factor: 3.896

2.  Primary stability of anterior lumbar stabilization: interdependence of implant type and endplate retention or removal.

Authors:  Christian H Flamme; Nadine von der Heide; Caroline Heymann; Christof Hurschler
Journal:  Eur Spine J       Date:  2005-08-10       Impact factor: 3.134

3.  A comparison of commercially available demineralized bone matrix for spinal fusion.

Authors:  Jeffrey C Wang; A Alanay; Davies Mark; Linda E A Kanim; Pat A Campbell; Edgar G Dawson; Jay R Lieberman
Journal:  Eur Spine J       Date:  2007-01-05       Impact factor: 3.134

Review 4.  An evaluation of biomaterials and osteobiologics for arthrodesis achievement in spine surgery.

Authors:  Joon S Yoo; Junyoung Ahn; Dillon S Patel; Nadia M Hrynewycz; Thomas S Brundage; Kern Singh
Journal:  Ann Transl Med       Date:  2019-09

5.  Histologic and histomorphometric evaluation of bone regeneration using nanocrystalline hydroxyapatite and human freeze-dried bone graft : An experimental study in rabbit.

Authors:  Rokhsareh Sadeghi; Mohammad Najafi; Hassan Semyari; Fatemeh Mashhadiabbas
Journal:  J Orofac Orthop       Date:  2017-01-27       Impact factor: 1.938

6.  Correlative radiological, self-assessment and clinical analysis of evolution in instrumented dorsal and lateral fusion for degenerative lumbar spine disease. Autograft versus coralline hydroxyapatite.

Authors:  Panagiotis Korovessis; Georgios Koureas; Spyridon Zacharatos; Zisis Papazisis; Elias Lambiris
Journal:  Eur Spine J       Date:  2005-03-24       Impact factor: 3.134

7.  Effect of Oxy133, an osteogenic oxysterol, on new bone formation in rat two-level posterolateral fusion model.

Authors:  Zorica Buser; Susan Drapeau; Frank Stappenbeck; Renata C Pereira; Farhad Parhami; Jeffrey C Wang
Journal:  Eur Spine J       Date:  2017-05-25       Impact factor: 3.134

8.  Micro-computed tomography-based three-dimensional kinematic analysis during lateral bending for spinal fusion assessment in a rat posterolateral lumbar fusion model.

Authors:  Tomonori Yamaguchi; Nozomu Inoue; Robert L Sah; Yu-Po Lee; Alexander P Taborek; Gregory M Williams; Timothy A Moseley; Won C Bae; Koichi Masuda
Journal:  Tissue Eng Part C Methods       Date:  2014-01-09       Impact factor: 3.056

9.  Loading of VEGF to the heparin cross-linked demineralized bone matrix improves vascularization of the scaffold.

Authors:  Lei Chen; Zhengquan He; Bing Chen; Maojin Yang; Yannan Zhao; Wenjie Sun; Zhifeng Xiao; Jing Zhang; Jianwu Dai
Journal:  J Mater Sci Mater Med       Date:  2009-07-26       Impact factor: 3.896

10.  125I-labeled OP-1 is locally retained in a rabbit lumbar fusion model.

Authors:  Benjamin P Erickson; Allen R Pierce; Andrew K Simpson; John Nash; Jonathan N Grauer
Journal:  Clin Orthop Relat Res       Date:  2008-01-03       Impact factor: 4.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.